American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

Most adults know nothing about CKM syndrome—but it impacts nearly everyone
Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.
Hospital in Mexico earns first heart failure certification of its kind
A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.
Advances in imaging could help predict, prevent heart attacks
Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.
Long-term data highlight Ross procedure's safety, effectiveness in younger patients
TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.
Common methods for attributing cardiac care in ACOs may be falling short
As the United States continues to move toward quality-based care, ACOs need to rethink the way they attribute care to cardiologists and other members of the heart team.

Jason Andrade, MD, FRCPC, FHRS, director of electrophysiology, Vancouver General Hospital, clinical associate professor, University of British Columbia, and principal investigator for the PROGRESSIVE AF trial, explains how cryoablation can be used as a front-line treatment for atrial fibrillation (AFib). He presented this late-breaking trial at the American Heart Association (AHA) 2022 meeting, which showed the therapy can be used instead of trying drug therapy first. #AHA22 #EPeeps

VIDEO: Cryoablation can be used as frontline therapy before drugs: PROGRESSIVE AF trial

Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker.

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients.

U.S. Food and Drug Administration Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association (AHA) last week about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.

FDA Commissioner Robert Califf calls on cardiology to address health inequities and combat misinformation

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system.

Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022

Links to the American Heart Association 2022 late-breaking studies

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

Late-breaking cardiovascular study presentation at AHA 2022. #AHA22

VIDEO: Key takeaways from AHA 2022

Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

Medtronic’s Arctic Front cryoballoon catheters

Treating AFib early with cryoablation reduces risk of disease progression, repeat hospitalization

“The evidence shows increasingly that it’s time to rethink how we approach the treatment of AFib,” one researcher said.

Bypass surgery the best way to limit amputations, death among CLTI patients

Researchers examined data from more than 1,800 CLTI patients, comparing bypass surgery with minimally invasive treatment options such as angioplasty and stenting.

Fish oil, garlic and other ‘heart-healthy’ dietary supplements do not improve cholesterol levels

The new analysis was presented at the AHA Scientific Sessions 2022 conference and simultaneously published in the Journal of the American College of Cardiology.

American Heart Association (AHA)

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

Hospital in Mexico earns first heart failure certification of its kind

Advances in imaging could help predict, prevent heart attacks

Long-term data highlight Ross procedure's safety, effectiveness in younger patients

Common methods for attributing cardiac care in ACOs may be falling short